Zinc in PDB 6tgd: Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31
Protein crystallography data
The structure of Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31, PDB code: 6tgd
was solved by
L.Maso,
F.Spirakis,
M.Santucci,
C.Simon,
J.D.Docquier,
G.Cruciani,
M.P.Costi,
D.Tondi,
L.Cendron,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
42.42 /
1.33
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
69.678,
73.665,
77.501,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
18.5 /
20.7
|
Other elements in 6tgd:
The structure of Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31 also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31
(pdb code 6tgd). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31, PDB code: 6tgd:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 6tgd
Go back to
Zinc Binding Sites List in 6tgd
Zinc binding site 1 out
of 4 in the Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn301
b:20.0
occ:1.00
|
ND1
|
A:HIS122
|
1.9
|
16.6
|
1.0
|
NE2
|
A:HIS120
|
2.0
|
16.9
|
1.0
|
NE2
|
A:HIS189
|
2.0
|
16.1
|
1.0
|
N04
|
A:N8Q305
|
2.2
|
30.7
|
1.0
|
CE1
|
A:HIS122
|
2.9
|
17.1
|
1.0
|
CE1
|
A:HIS120
|
2.9
|
17.4
|
1.0
|
CG
|
A:HIS122
|
3.0
|
16.4
|
1.0
|
CD2
|
A:HIS189
|
3.0
|
17.1
|
1.0
|
CD2
|
A:HIS120
|
3.1
|
15.3
|
1.0
|
CE1
|
A:HIS189
|
3.1
|
18.0
|
1.0
|
N05
|
A:N8Q305
|
3.1
|
26.2
|
1.0
|
C13
|
A:N8Q305
|
3.2
|
25.7
|
1.0
|
CB
|
A:HIS122
|
3.3
|
15.7
|
1.0
|
S01
|
A:N8Q305
|
3.8
|
22.5
|
1.0
|
ND1
|
A:HIS120
|
4.1
|
15.8
|
1.0
|
NE2
|
A:HIS122
|
4.1
|
18.7
|
1.0
|
CD2
|
A:HIS122
|
4.1
|
16.5
|
1.0
|
OD1
|
A:ASP124
|
4.1
|
17.5
|
1.0
|
CG
|
A:HIS120
|
4.1
|
15.3
|
1.0
|
ND1
|
A:HIS189
|
4.2
|
15.8
|
1.0
|
CG
|
A:HIS189
|
4.2
|
14.3
|
1.0
|
C12
|
A:N8Q305
|
4.2
|
27.7
|
1.0
|
N03
|
A:N8Q305
|
4.2
|
27.8
|
1.0
|
CG2
|
A:THR190
|
4.3
|
15.1
|
1.0
|
ZN
|
A:ZN302
|
4.4
|
16.8
|
1.0
|
SG
|
A:CYS208
|
4.6
|
15.0
|
1.0
|
CB
|
A:CYS208
|
4.6
|
14.3
|
1.0
|
CA
|
A:HIS122
|
4.8
|
14.6
|
1.0
|
O
|
A:HOH490
|
4.8
|
27.0
|
1.0
|
CG
|
A:ASP124
|
5.0
|
15.8
|
1.0
|
|
Zinc binding site 2 out
of 4 in 6tgd
Go back to
Zinc Binding Sites List in 6tgd
Zinc binding site 2 out
of 4 in the Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn302
b:16.8
occ:1.00
|
OD2
|
A:ASP124
|
2.0
|
15.1
|
1.0
|
NE2
|
A:HIS250
|
2.1
|
16.8
|
1.0
|
S01
|
A:N8Q305
|
2.2
|
22.5
|
1.0
|
SG
|
A:CYS208
|
2.3
|
15.0
|
1.0
|
C13
|
A:N8Q305
|
2.8
|
25.7
|
1.0
|
CG
|
A:ASP124
|
3.0
|
15.8
|
1.0
|
CE1
|
A:HIS250
|
3.0
|
16.2
|
1.0
|
CD2
|
A:HIS250
|
3.1
|
15.2
|
1.0
|
CB
|
A:CYS208
|
3.3
|
14.3
|
1.0
|
OD1
|
A:ASP124
|
3.4
|
17.5
|
1.0
|
N03
|
A:N8Q305
|
3.5
|
27.8
|
1.0
|
C10
|
A:N8Q305
|
3.6
|
29.8
|
1.0
|
N04
|
A:N8Q305
|
3.7
|
30.7
|
1.0
|
CB
|
A:SER249
|
4.1
|
13.8
|
1.0
|
ND1
|
A:HIS250
|
4.2
|
15.7
|
1.0
|
CG
|
A:HIS250
|
4.2
|
16.0
|
1.0
|
CB
|
A:ASP124
|
4.3
|
14.5
|
1.0
|
ZN
|
A:ZN301
|
4.4
|
20.0
|
1.0
|
CA
|
A:CYS208
|
4.5
|
14.7
|
1.0
|
OG
|
A:SER249
|
4.5
|
14.7
|
1.0
|
C12
|
A:N8Q305
|
4.5
|
27.7
|
1.0
|
CE1
|
A:HIS120
|
4.6
|
17.4
|
1.0
|
N05
|
A:N8Q305
|
4.6
|
26.2
|
1.0
|
NE2
|
A:HIS189
|
4.7
|
16.1
|
1.0
|
O
|
A:HOH492
|
4.8
|
33.2
|
1.0
|
C08
|
A:N8Q305
|
4.8
|
35.1
|
1.0
|
C07
|
A:N8Q305
|
4.8
|
36.0
|
1.0
|
NE2
|
A:HIS120
|
5.0
|
16.9
|
1.0
|
CE1
|
A:HIS189
|
5.0
|
18.0
|
1.0
|
|
Zinc binding site 3 out
of 4 in 6tgd
Go back to
Zinc Binding Sites List in 6tgd
Zinc binding site 3 out
of 4 in the Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn301
b:20.3
occ:1.00
|
ND1
|
B:HIS122
|
2.0
|
20.0
|
1.0
|
NE2
|
B:HIS189
|
2.0
|
16.8
|
1.0
|
NE2
|
B:HIS120
|
2.1
|
15.3
|
1.0
|
N04
|
B:N8Q305
|
2.1
|
34.1
|
1.0
|
CG
|
B:HIS122
|
3.0
|
16.6
|
1.0
|
N05
|
B:N8Q305
|
3.0
|
32.3
|
1.0
|
CE1
|
B:HIS122
|
3.0
|
16.2
|
1.0
|
CD2
|
B:HIS189
|
3.0
|
16.6
|
1.0
|
CE1
|
B:HIS120
|
3.1
|
16.0
|
1.0
|
CD2
|
B:HIS120
|
3.1
|
13.9
|
1.0
|
CE1
|
B:HIS189
|
3.1
|
18.9
|
1.0
|
C13
|
B:N8Q305
|
3.1
|
35.6
|
1.0
|
CB
|
B:HIS122
|
3.3
|
15.2
|
1.0
|
S01
|
B:N8Q305
|
3.7
|
26.1
|
1.0
|
C12
|
B:N8Q305
|
4.1
|
30.5
|
1.0
|
NE2
|
B:HIS122
|
4.1
|
17.2
|
1.0
|
CD2
|
B:HIS122
|
4.1
|
18.1
|
1.0
|
N03
|
B:N8Q305
|
4.1
|
29.4
|
1.0
|
ND1
|
B:HIS120
|
4.2
|
16.4
|
1.0
|
CG
|
B:HIS189
|
4.2
|
15.1
|
1.0
|
ND1
|
B:HIS189
|
4.2
|
17.2
|
1.0
|
OD1
|
B:ASP124
|
4.2
|
16.1
|
1.0
|
CG
|
B:HIS120
|
4.2
|
15.1
|
1.0
|
CG2
|
B:THR190
|
4.3
|
16.5
|
1.0
|
ZN
|
B:ZN302
|
4.5
|
17.6
|
1.0
|
SG
|
B:CYS208
|
4.7
|
16.0
|
1.0
|
CB
|
B:CYS208
|
4.7
|
13.8
|
1.0
|
O
|
B:HOH479
|
4.8
|
29.7
|
1.0
|
CA
|
B:HIS122
|
4.8
|
13.6
|
1.0
|
|
Zinc binding site 4 out
of 4 in 6tgd
Go back to
Zinc Binding Sites List in 6tgd
Zinc binding site 4 out
of 4 in the Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Ndm-1 in Complex with Triazole-Based Inhibitor OP31 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn302
b:17.6
occ:1.00
|
OD2
|
B:ASP124
|
2.0
|
15.6
|
1.0
|
NE2
|
B:HIS250
|
2.0
|
15.7
|
1.0
|
S01
|
B:N8Q305
|
2.2
|
26.1
|
1.0
|
SG
|
B:CYS208
|
2.3
|
16.0
|
1.0
|
C13
|
B:N8Q305
|
2.9
|
35.6
|
1.0
|
CE1
|
B:HIS250
|
3.0
|
15.1
|
1.0
|
CD2
|
B:HIS250
|
3.0
|
14.3
|
1.0
|
CG
|
B:ASP124
|
3.0
|
15.5
|
1.0
|
CB
|
B:CYS208
|
3.3
|
13.8
|
1.0
|
C10
|
B:N8Q305
|
3.4
|
32.3
|
1.0
|
N03
|
B:N8Q305
|
3.4
|
29.4
|
1.0
|
OD1
|
B:ASP124
|
3.5
|
16.1
|
1.0
|
N04
|
B:N8Q305
|
3.8
|
34.1
|
1.0
|
CB
|
B:SER249
|
4.1
|
13.6
|
1.0
|
ND1
|
B:HIS250
|
4.1
|
16.2
|
1.0
|
CG
|
B:HIS250
|
4.2
|
15.3
|
1.0
|
C08
|
B:N8Q305
|
4.2
|
38.1
|
1.0
|
CB
|
B:ASP124
|
4.3
|
14.1
|
1.0
|
C07
|
B:N8Q305
|
4.3
|
37.5
|
1.0
|
OG
|
B:SER249
|
4.4
|
15.6
|
1.0
|
CA
|
B:CYS208
|
4.4
|
13.6
|
1.0
|
ZN
|
B:ZN301
|
4.5
|
20.3
|
1.0
|
C12
|
B:N8Q305
|
4.5
|
30.5
|
1.0
|
CE1
|
B:HIS120
|
4.6
|
16.0
|
1.0
|
N05
|
B:N8Q305
|
4.7
|
32.3
|
1.0
|
NE2
|
B:HIS189
|
4.8
|
16.8
|
1.0
|
NE2
|
B:HIS120
|
4.9
|
15.3
|
1.0
|
CE
|
B:LYS125
|
4.9
|
14.2
|
1.0
|
|
Reference:
F.Spyrakis,
M.Santucci,
L.Maso,
S.Cross,
E.Gianquinto,
F.Sannio,
F.Verdirosa,
F.De Luca,
J.D.Docquier,
L.Cendron,
D.Tondi,
A.Venturelli,
G.Cruciani,
M.P.Costi.
Virtual Screening Identifies Broad-Spectrum Beta-Lactamase Inhibitors with Activity on Clinically Relevant Serine- and Metallo-Carbapenemases. Sci Rep V. 10 12763 2020.
ISSN: ESSN 2045-2322
PubMed: 32728062
DOI: 10.1038/S41598-020-69431-Y
Page generated: Tue Oct 29 07:58:22 2024
|